Maria Melanson

503 total citations
15 papers, 293 citations indexed

About

Maria Melanson is a scholar working on Neurology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Maria Melanson has authored 15 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 6 papers in Pathology and Forensic Medicine and 4 papers in Oncology. Recurrent topics in Maria Melanson's work include Multiple Sclerosis Research Studies (6 papers), Peripheral Neuropathies and Disorders (4 papers) and Pain Mechanisms and Treatments (3 papers). Maria Melanson is often cited by papers focused on Multiple Sclerosis Research Studies (6 papers), Peripheral Neuropathies and Disorders (4 papers) and Pain Mechanisms and Treatments (3 papers). Maria Melanson collaborates with scholars based in Canada, United States and Spain. Maria Melanson's co-authors include Mike Namaka, Ian Sutton, Michael Namaka, Yuewen Gong, Christine Leong, Emma E. Frost, Andrew Gomori, David D. Eisenstat, Keith R. Fowke and Kevin G. Becker and has published in prestigious journals such as Neurology, European Journal of Immunology and Multiple Sclerosis Journal.

In The Last Decade

Maria Melanson

13 papers receiving 280 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria Melanson Canada 9 104 94 64 57 43 15 293
Rafaela Mano Guimarães Brazil 10 199 1.9× 35 0.4× 34 0.5× 94 1.6× 22 0.5× 14 457
Lee A. Selznick United States 10 159 1.5× 79 0.8× 72 1.1× 185 3.2× 43 1.0× 12 446
Young Nam Kwon South Korea 10 85 0.8× 87 0.9× 130 2.0× 83 1.5× 14 0.3× 36 330
Emanuel Rechthand United States 12 138 1.3× 23 0.2× 68 1.1× 106 1.9× 15 0.3× 15 429
Ryan J. Bevan United Kingdom 12 85 0.8× 133 1.4× 47 0.7× 107 1.9× 8 0.2× 19 393
Sara Zagaglia Italy 7 31 0.3× 62 0.7× 40 0.6× 54 0.9× 19 0.4× 11 207
Anna Ticca Italy 12 46 0.4× 147 1.6× 214 3.3× 106 1.9× 15 0.3× 17 448
Barbara Gisevius Germany 7 62 0.6× 56 0.6× 35 0.5× 138 2.4× 10 0.2× 16 329
Kiandokht Keyhanian United States 11 30 0.3× 89 0.9× 199 3.1× 81 1.4× 19 0.4× 19 398

Countries citing papers authored by Maria Melanson

Since Specialization
Citations

This map shows the geographic impact of Maria Melanson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Melanson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Melanson more than expected).

Fields of papers citing papers by Maria Melanson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Melanson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Melanson. The network helps show where Maria Melanson may publish in the future.

Co-authorship network of co-authors of Maria Melanson

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Melanson. A scholar is included among the top collaborators of Maria Melanson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Melanson. Maria Melanson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Truty, Rebecca, et al.. (2019). Alnylam Act®: Heterogenous Disease Manifestations of Hereditary Transthyretin-Mediated Amyloidosis. Journal of Cardiac Failure. 25(8). S111–S112. 1 indexed citations
2.
Arroyo, Rafael, Jennifer D. Guo, David Margolin, et al.. (2019). Impact of alemtuzumab on health-related quality of life over 6 years in CARE-MS II trial extension patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal. 26(8). 955–963. 13 indexed citations
3.
4.
5.
6.
Freedman, Mark S., Aaron Boster, Maria Melanson, et al.. (2013). Long-Term Efficacy, Safety and Tolerability of Ponesimod in Patients with Relapsing–Remitting Multiple Sclerosis (P01.156). Neurology. 80(7_supplement). 1 indexed citations
7.
Mulvey, Michael R., Malcolm Doupe, Christine Leong, et al.. (2011). Staphylococcus aureus harbouring Enterotoxin A as a possible risk factor for multiple sclerosis exacerbations. Multiple Sclerosis Journal. 17(4). 397–403. 38 indexed citations
8.
Melanson, Maria, Christine Leong, Emma E. Frost, et al.. (2010). Fatigue and Cognition in Patients with Relapsing Multiple Sclerosis Treated with Interferon Beta. International Journal of Neuroscience. 120(10). 631–640. 25 indexed citations
9.
Melanson, Maria, David D. Eisenstat, Yuewen Gong, et al.. (2009). Experimental autoimmune encephalomyelitis-induced upregulation of tumor necrosis factor-alpha in the dorsal root ganglia. Multiple Sclerosis Journal. 15(10). 1135–1145. 22 indexed citations
10.
Gong, Yuewen, Hong Shen, David D. Eisenstat, et al.. (2008). Axotomy-induced up-regulation of tumor necrosis factor-alpha in the dorsal root ganglia. Neurological Research. 30(6). 623–631. 17 indexed citations
11.
Namaka, Mike, et al.. (2008). Examining the evidence: complementary adjunctive therapies for multiple sclerosis. Neurological Research. 30(7). 710–719. 19 indexed citations
12.
Namaka, Mike, et al.. (2005). Corticosteroids and Multiple Sclerosis: To Treat or Not to Treat?. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 138(6). 1–13. 2 indexed citations
13.
Namaka, Mike, et al.. (2005). The clinical importance of neutralizing antibodies in relapsing-remitting multiple sclerosis. Current Medical Research and Opinion. 22(2). 223–239. 21 indexed citations
14.
Mayne, Michael, Hong Kong, Paul J. McLaren, et al.. (2004). CYFIP2 is highly abundant in CD4+ cells from multiple sclerosis patients and is involved in T cell adhesion. European Journal of Immunology. 34(4). 1217–1227. 32 indexed citations
15.
Namaka, Mike, et al.. (2004). A treatment algorithm for neuropathic pain. Clinical Therapeutics. 26(7). 951–979. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rafaela Mano Guimarães Breakdown of academic impact, for papers by Lee A. Selznick Breakdown of academic impact, for papers by Young Nam Kwon Breakdown of academic impact, for papers by Emanuel Rechthand Breakdown of academic impact, for papers by Ryan J. Bevan Breakdown of academic impact, for papers by Sara Zagaglia Breakdown of academic impact, for papers by Anna Ticca Breakdown of academic impact, for papers by Barbara Gisevius Breakdown of academic impact, for papers by Kiandokht Keyhanian
Rankless by CCL
2026